Women Report Less Poststroke Medication Adherence Than Men
By Lori Solomon HealthDay Reporter
TUESDAY, Dec. 10, 2024 -- Poststroke medication nonadherence is more prevalent among U.S. women than men, according to a study published online Dec. 4 in the Journal of the American Heart Association.
Chen Chen, M.P.H., from the University of Michigan School of Public Health in Ann Arbor, and colleagues examined sex differences in poststroke medication adherence, overall and by drug class. The analysis included 1,324 patients with first‐ever ischemic stroke with self‐reported medication adherence evaluated at 90 days after stroke.
The researchers found that women were more likely to report nonadherence to cholesterol‐lowering drugs (prevalence ratio [PR], 1.80; 95 percent confidence interval [CI], 1.14 to 2.84) and antiplatelets (PR, 1.53; 95 percent CI, 1.003 to 2.34). Results were attenuated when adjusting for obesity, whereas adjusting for age, marital status, access to care, smoking, and alcohol consumption accentuated sex differences. The sex difference for nonadherence to cholesterol‐lowering drugs was modified by race and ethnicity, with a larger sex difference in Mexican American individuals (PR, 3.00; 95 percent CI, 1.65 to 5.48) versus non‐Hispanic White individuals (PR, 1.30; 95 percent CI, 0.52 to 3.27). There were no significant sex differences for nonadherence to antihypertensives and overall nonadherence.
"More specifically designed studies among U.S. populations are needed to replicate our findings and understand the unique pattern of sex differences in nonadherence to different secondary stroke prevention drugs," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted December 2024
Read this next
P2Y12 Inhibitor Monotherapy Beneficial for Patients Who Undergo PCI
FRIDAY, June 6, 2025 -- For patients who undergo percutaneous coronary intervention (PCI) and discontinue dual antiplatelet therapy (DAPT), P2Y12 inhibitor monotherapy is...
Longer In-Bed Time Linked to Small Vessel Disease Burden in TIA/Mild Stroke
FRIDAY, May 30, 2025 -- For adult patients with transient ischemic attack (TIA)/mild stroke, disturbed sleep is associated with greater cerebral small vessel disease (SVD) burden...
ACP Issues Clinical Guideline for Statin Use in Persons With HIV
THURSDAY, May 29, 2025 -- In a clinical guideline issued by the American College of Physicians and published online May 27 in the Annals of Internal Medicine, recommendations are...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.